Skip to Main Content

Paper Details

Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
J Hepatol
229
2018
7q22, ARID1A, ATR, BRCA1, BRCA2, BTC, BTCs, Biliary tract cancers, CDCs, DCCs, GBCs, ICCs, KRAS, MLH1, MSH2, MUC17, NF1, PBRM1, PHCs, RAD51D, SMAD4, TP53, biliary tract cancers, cancer, cancer-, cancer-predisposing genes, cell-of-origin, cystic duct cancers, distal cholangiocarcinomas, driver genes, gallbladder, germline, hepatitis, hepatocyte, intrahepatic cholangiocarcinomas, mutated genes, patient, patients, peri-hilar type cholangiocarcinomas, predisposing genes
Author NameAffiliation
Rosa KarlicUniversity of Zagreb
Paz PolakBroad Institute of MIT and Harvard
Paz PolakBroad Institute of MIT and Harvard
Jaegil KimBroad Institute of MIT and Harvard
Akihiro FujimotoRIKEN Center for Integrative Medical Sciences
Hiroko TanakaHuman Genome Center, The Institute of Medical Science, The University of Tokyo
Michiaki KuboRIKEN Center for Integrative Medical Sciences
Satoru MiyanoHuman Genome Center, The Institute of Medical Science, The University of Tokyo
Gad GetzBroad Institute of MIT and Harvard
Gad GetzBroad Institute of MIT and Harvard
Hidewaki NakagawaRIKEN Center for Integrative Medical Sciences
  • 1 - 11

Datasets

Release 1.2